BLTE News and Press, Belite Bio Inc From 07/27/23

Tinlarebant (a/k/a LBS-008) is Belite Bio’s orally administered tablet intended to slow disease progression in subjects with Stargardt Disease (STGD1) and Geographic Atrophy (GA) in advanced Dry Age-related Macular Degeneration (Dry AMD) There are no approved oral or non-invasive tre...

Tinlarebant (a/k/a LBS-008) is Belite Bio’s orally administered tablet intended to slow disease progression in patients with Stargardt Disease (STGD1) and Geographic Atrophy (GA) in advanced Dry Age-related Macular Degeneration (Dry AMD) 90 patients completed enrollment across 11 c...

2023-06-30 16:09:14 ET Shares of Belite Bio (NASDAQ: BLTE) were up more than 26% for the week as of Friday's close after rising as much as 35.7%, according to data provided by S&P Global Market Intelligence . The clinical-stage biotech company's stock closed last week at...

2023-06-26 12:52:19 ET Gainers: Benitec Biopharma ( BNTC ) +76% . MoonLake Immunotherapeutics ( MLTX ) +68% . Paltalk ( PALT ) +27% . Whole Earth Brands ( FREE ) +26% . Shengfeng Development Limited ( SFWL ) +26% . Belite Bio...

2023-06-15 12:34:14 ET Summary BLTE works with retinal disease patients. Their lead asset has positive phase 1 data. Their cash position and trial patient population are two worries. Belite Bio ( BLTE ) is a small company with multiple phase 3 trials targeting re...

2023-05-31 12:22:53 ET Shares of Belite Bio (NASDAQ: BLTE) were down 38% Wednesday morning after the clinical-stage biopharmaceutical company said it planned to do an underwritten public stock offering. The company specializes on therapies to treat blindness, diabetes, and liver dis...

2023-05-31 10:05:20 ET Gainers: Marker Therapeutics ( MRKR ) +34% . Nano-X Imaging ( NNOX ) +13% . Zai Lab ( ZLAB ) +9% . Invivyd ( IVVD ) +8% . Corbus Pharmaceuticals ( CRBP ) +7% . Losers: Belite Bio ( BLTE ) ...

2023-05-31 08:32:12 ET Belite Bio ( BLTE ) -37% commences public offering of American Depositary Shares of $30M. Advance Auto Parts ( AAP ) -27% after Q1 earning release . Ambarella ( AMBA ) -20% after Q1 earning release . FG Financial Group (FG...

2023-05-31 03:01:56 ET Belite Bio ( NASDAQ: BLTE ) slumps 38% as it prices an underwritten public offering of 2M ADSs , each representing one of its ordinary shares, and warrants to purchase 2M ordinary shares represented by ADSs, at a public offering price of $15.00 per ADS...

SAN DIEGO, May 30, 2023 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio” or the “Company”), a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting retinal degenerative eye diseases which have si...